Wednesday, October 19, 2016
Excerpt From My "IS YOUR MEDICATION DEPLETING THE CO-ENZYME Q10 IN YOUR BODY?" Newsletter
Though always working in our bodies, Co-Q10 was only first isolated and described by Dr Frederick Crane in 1957. Dr Peter Marshall won the 1978 Nobel Prize in Chemistry for his discoveries of the mechanisms of energy transfer in the body, part of which involved the role of Co-Q10. In 1974 the Japanese incorporated it as a prescription item into their treatment for congestive heart failure & other heart disorders. Life Extension Foundation introduced Co-Q10 to the U.S. in 1983. It later became widely available as an OTC nutrient supplement.
Co-Q10 has and is still being extensively studied and is now the 3rd most sold dietary ingredient in the U.S. after the Omega-3’s and multivitamins.
Some of the research clinical trials using CoQ10 as adjunctive therapy involve myalgias & myopathies, statin induced myopathies, myopathic encephalopathies (ME), muscular dystrophy, Mitochondrial Disease, fatigue syndromes, depression, Parkinson’s Disease, Friedrich’s Ataxia, Amyotrophic Lateral Sclerosis, other neurodegenerative diseases, cardiomyopathy, heart failure, heart protection during heart surgery, heart arrhythmia, angina, mitral valve prolapse, heart protection for those on the anthracycline chemotherapeutic agents, hypertension, protection in stroke, LDL cholesterol, blood vessel dilation, migraine, cyclic vomiting syndrome, asthma, age-related macular degeneration, decreased sperm count & motility, chronic kidney failure, breast & other cancers, myelodysplastic syndrome, post surgical melanoma, chronic gum disease, immune function, AIDS, aging, and skin health.